CoChat

Lowering the Cut Point for Impaired Fasting Glucose

Open access
Schriger, David L., Lorber, Brett · 2004 · Diabetes Care
Cited by 66

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

First a disclaimer, neither of us is a diabetologist, endocrinologist, or internist. We do not provide chronic care to people with diabetes. Our only credential relevant to the diagnosis of diabetes is our willingness to think logically and our conviction that the goal of guidelines and policies must be to optimize patient outcomes. From this perspective we are befuddled by the Expert Committee’s (1) decision to lower the cut point for impaired fasting glucose (IFG) from 110 to 100 mg/dl. In this commentary we explain why. With the publication of the Expert Committee’s report (1) in Diabetes Care in November 2003, the number of 25- to 74-year-olds in the U.S. with IFG instantly tripled from 10 to 35 million people (see appendix for all methods). We might expect that a decision affecting over 25 million people would be based on some type of explicit modeling that established the benefits of the new cut point. Unfortunately, the Expert Committee’s report contains no such analysis. In fact, the committee states “we do not yet know the total benefit or the total cost to an individual who is designated at risk for diabetes by either test, by any criteria” (1). Given this, the Expert Committee might have concluded, “and we therefore have insufficient evidence to newly label 25 million people with IFG” (1). Instead, the committee offers two forms of justification for its decision: 1 ) epidemiological data that suggest that those with an FPG of 100–109 mg/dl may be at higher risk for developing diabetes than those with a level below 100 mg/dl; and 2 ) the desire to have the IFG population have greater homology to the impaired glucose tolerance (IGT) population. The first argument fails because identifying those at higher risk in no way insures that their health will be improved …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.27.2.592

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 66

Metadata

Authors
Schriger, D. L., & Lorber, B.
Venue
Diabetes Care
Published
2004-02-01
Volume
27
Issue
2
Pages
592-595
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2059694318
Cited by
66
References
5
FWCI
6.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lowering the Cut Point for Impaired Fasting Glucose. https://app.cochat.ai/papers/10.2337/diacare.27.2.592
The paper
Schriger, D. L., & Lorber, B. (2004). Lowering the Cut Point for Impaired Fasting Glucose. Diabetes Care. https://doi.org/10.2337/diacare.27.2.592

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.